Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Raphael Rousseau currently holds 2,900 shares of Gritstone Oncology, Inc. (GRTS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raphael Rousseau has been a net seller of GRTS stock. They have purchased $0 and sold $735.0K worth of shares.
Raphael Rousseau's most recent insider trade was on May 27, 2021, when they sold 2,900 shares at $0.76 per share.
Raphael Rousseau serves as Executive at Gritstone Oncology, Inc. (GRTS). They have executed 9 insider transactions totaling $735.0K over their tenure at the company.
Raphael Rousseau holds the position of Executive at Gritstone Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Raphael Rousseau has shown a selling trading pattern, with $0 in total purchases and $735.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Raphael Rousseau was on Jan 19, 2021, when they sold $350.6K worth of GRTS shares. This transaction involved 20,000 shares at $17.53 per share.
Raphael Rousseau currently owns 2,900 shares of Gritstone Oncology, Inc. (GRTS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Raphael Rousseau's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Raphael Rousseau has 9 Form 4 filings on record as an insider at Gritstone Oncology, Inc..
Set alerts for Raphael Rousseau and 40,000+ other insiders.